LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 40.14 84.90 2235 3682 0.6070 0.8246
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 40.14 84.90 246 3682 0.0668 0.2161
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 40.14 84.90 2029 3682 0.5511 0.7924
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 41.84 84.90 130 4003 0.0325 0.0797
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 41.84 84.90 2124 4003 0.5306 0.7845
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 41.84 84.90 2224 4003 0.5556 0.7993
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 41.84 84.90 2245 4003 0.5608 0.8024
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 41.84 84.90 293 4003 0.0732 0.2496
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 41.84 84.90 2227 4003 0.5563 0.7998
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 43.55 84.90 146 4287 0.0340 0.1006
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 43.55 84.90 2246 4287 0.5238 0.7840
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 43.55 84.90 2294 4287 0.5350 0.7907
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 43.55 84.90 2316 4287 0.5401 0.7937
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 43.55 84.90 318 4287 0.0742 0.2629
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 43.55 84.90 2232 4287 0.5205 0.7820
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 45.25 84.90 159 4539 0.0350 0.1155
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 45.25 84.90 2354 4539 0.5185 0.7838
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 45.25 84.90 2501 4539 0.5509 0.8027
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 45.25 84.90 2517 4539 0.5544 0.8047
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 45.25 84.90 346 4539 0.0762 0.2773
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 45.25 84.90 2329 4539 0.5130 0.7805
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 46.95 84.90 191 4952 0.0386 0.1482
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 46.95 84.90 2483 4952 0.5014 0.7779
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 46.95 84.90 2664 4952 0.5379 0.7994
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 46.95 84.90 2681 4952 0.5413 0.8013
MN20160318_Q02
K07